Plasma levels of neuropeptides and metabolic hormones, and sleepiness in obstructive sleep apnea

Respiratory Medicine

Volumn 105, Issue 12, 2011, Pages 1954-1960

  Sanchez De La Torre M ^a,j   Barcelo A ^b,j   Pierola J ^b,j   Esquinas, C ^a,j   De La Pena M ^b,j   Duran Cantolla J ^c,j   Capote, F ^d   Masa, J F ^e,j   Marin, J M ^f,j   Vila M ^a   Cao, G ^a   Martinez, M ^a,j   De Lecea, L ^g   Gozal, D ^h   Montserrat, J M ^i,j   Barbe F ^a,j  

^a HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

^b HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^e HOSPITAL SAN PEDRO DE ALCÁNTARA   (Spain)

^f HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^g STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF CHICAGO   (United States)

ⁱ HOSPITAL CLÍNIC   (Spain)

^j INSTITUTO DE SALUD CARLOS III   (Spain)

more..

Author keywords

EDS; Metabolism; OSA; Sleep apnea

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; GHRELIN; LEPTIN; NEUROPEPTIDE Y; OREXIN A;

ADULT; APNEA HYPOPNEA INDEX; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DAYTIME SOMNOLENCE; ENERGY BALANCE; EPWORTH SLEEPINESS SCALE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGULATORY MECHANISM; SLEEP APNEA SYNDROME; SLEEP TIME; SLEEP WAKING CYCLE; SYMPATHETIC TONE;

BIOLOGICAL MARKERS; BODY MASS INDEX; DISORDERS OF EXCESSIVE SOMNOLENCE; FEMALE; GHRELIN; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; NEUROPEPTIDES; POLYSOMNOGRAPHY; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 81155130881     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2011.08.014     Document Type: Article

References (32)

1. J. Duran, S. Esnaola, R. Rubio, and A. Iztueta Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr Am J Respir Crit Care Med 163 2001 685 689 (Pubitemid 32230829)
2. C. Hernandez, J. Duran-Cantolla, P. Lloberes, and M. Gonzalez Innovations in the epidemiology, natural history, diagnosis and treatment of sleep apnea-hypopnea syndrome Arch Bronconeumol 45 Suppl. 1 2009 3 10
3. A.A.O.S. Medicine The international calssification of sleep disorders, revised, diagnostic, and coding manual 1997 Davies Printing Co Rochester
4. B. Briones, N. Adams, M. Strauss, C. Rosenberg, C. Whalen, and M. Carskadon Relationship between sleepiness and general health status Sleep 19 1996 583 588 (Pubitemid 26339704)
5. C. Lombardi, G. Parati, P. Cortelli, F. Provini, R. Vetrugno, and G. Plazzi Daytime sleepiness and neural cardiac modulation in sleep-related breathing disorders J Sleep Res 17 2008 263 270
6. J.J. Askenasy Sleep related breathing disorders. Sleep and wakefulness: sleep wakefulness vol. 6 1983 Wiley Eastern Limited Delhi pp. 312-318
7. U. Seneviratne, and K. Puvanendran Excessive daytime sleepiness in obstructive sleep apnea: prevalence, severity, and predictors Sleep Med 5 2004 339 343 (Pubitemid 38842730)
8. A. Barceló, F. Barbe, M. de la Pena, P. Martinez, J.B. Soriano, and J. Pierola Insulin resistance and daytime sleepiness in patients with sleep apnoea Thorax 63 2008 946 950
9. B. Baranowska, A. Baranowska-Bik, W. Bik, and L. Martynska The role of leptin and orexins in the dysfunction of hypothalamo-pituitary-gonadal regulation and in the mechanism of hyperactivity in patients with anorexia nervosa Neuro Endocrinol Lett 29 2008 37 40
10. C.R. Baumann, and C.L. Bassetti Hypocretins (orexins) and sleep-wake disorders Lancet Neurol 4 2005 673 682 (Pubitemid 41317302)
11. L.K. Brown A waist is a terrible thing to mind: central obesity, the metabolic syndrome, and sleep apnea hypopnea syndrome Chest 122 2002 774 778
12. K. Matsumura, T. Tsuchihashi, and I. Abe Central cardiovascular action of neuropeptide Y in conscious rabbits Hypertension 36 2000 1040 1044
13. T. Yokota, K. Oritani, I. Takahashi, J. Ishikawa, A. Matsuyama, and N. Ouchi Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages Blood 96 2000 1723 1732 (Pubitemid 30661055)
14. E. Chiner, J.M. Arriero, J. Signes-Costa, J. Marco, and I. Fuentes Validation of the Spanish version of the Epworth Sleepiness Scale in patients with a sleep apnea syndrome Arch Bronconeumol 35 1999 422 427
15. M. Carrera, F. Barbe, and A.G. Agusti Does the number of hypopnoeas influence therapy in patients with obstructive sleep apnoea? Respir Med 92 1998 1028 1031 (Pubitemid 28416833)
16. G. Copinschi, K. Spiegel, R. Leproult, and E. Van Cauter Pathophysiology of human circadian rhythms Novartis Found Symp 227 2000 143 157 discussion 57-62
17. K. Aksu, S. Firat Guven, F. Aksu, B. Ciftci, T. Ulukavak Ciftci, and S. Aksaray Obstructive sleep apnoea, cigarette smoking and plasma orexin-A in a sleep clinic cohort J Int Med Res 37 2009 331 340
18. A.J. Kastin, and V. Akerstrom Orexin A but not orexin B rapidly enters brain from blood by simple diffusion J Pharmacol Exp Ther 289 1999 219 223 (Pubitemid 29156032)
19. A.L. Kirchgessner, and M. Liu Orexin synthesis and response in the gut Neuron 24 1999 941 951 (Pubitemid 30017673)
20. X. Busquets, F. Barbé, A. Barceló, M. de la Peña, N. Sigritz, and L.R. Mayoralas Decreased plasma levels of orexin-A in sleep apnea Respiration 71 2004 575 579 (Pubitemid 40091429)
21. T. Nishijima, S. Sakurai, Z. Arihara, and K. Takahashi Plasma orexin-A-like immunoreactivity in patients with sleep apnea hypopnea syndrome Peptides 24 2003 407 411 (Pubitemid 36561212)
22. S. Sakurai, T. Nishijima, S. Takahashi, K. Yamauchi, Z. Arihara, and K. Takahashi Clinical significance of daytime plasma orexin-A-like immunoreactivity concentrations in patients with obstructive sleep apnea hypopnea syndrome Respiration 71 2004 380 384 (Pubitemid 39179174)
23. N. Igarashi, K. Tatsumi, A. Nakamura, S. Sakao, Y. Takiguchi, and T. Nishikawa Plasma orexin-A levels in obstructive sleep apnea-hypopnea syndrome Chest 124 2003 1381 1385 (Pubitemid 37290048)
24. X.M. Liao, and Q. Yu The changes and implications of plasma orexin-A levels in patients with obstructive sleep apnea-hypopnea syndrome Zhonghua Jie He He Hu Xi Za Zhi 28 2005 368 371 (Pubitemid 44785153)
25. A. Barceló, F. Barbé, E. Llompart, M. de la Peña, J. Durán-Cantolla, and A. Ladaria Neuropeptide Y and leptin in patients with obstructive sleep apnea syndrome: role of obesity Am J Respir Crit Care Med 171 2005 183 187 (Pubitemid 40105419)
26. I.A. Harsch, P.C. Konturek, C. Koebnick, P.P. Kuehnlein, F.S. Fuchs, and S. Pour Schahin Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment Eur Respir J 22 2003 251 257 (Pubitemid 36986993)
27. S. Taheri, L. Lin, D. Austin, T. Young, and E. Mignot Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index PLoS Med 1 2004 e62
28. H. Munzberg Leptin-signaling pathways and leptin resistance Forum Nutr 63 2003 123 132
29. O. Mediano, A. Barceló, M. de la Pena, D. Gozal, A. Agusti, and F. Barbe Daytime sleepiness and polysomnographic variables in sleep apnoea patients Eur Respir J 30 2007 110 113 (Pubitemid 47074014)
30. L.G. Olson, M.F. Cole, and A. Ambrogetti Correlations among Epworth Sleepiness Scale scores, multiple sleep latency tests and psychological symptoms J Sleep Res 7 1998 248 253 (Pubitemid 28515556)
31. M. Svensson, K.A. Franklin, J. Theorell-Haglow, and E. Lindberg Daytime sleepiness relates to snoring independent of the apnea-hypopnea index in women from the general population Chest 134 2008 919 924
32. E.O. Bixler, A.N. Vgontzas, H.M. Lin, S.L. Calhoun, A. Vela-Bueno, and A. Kales Excessive daytime sleepiness in a general population sample: The role of sleep apnea, age, obesity, diabetes, and depression J Clin Endocrinol Metab 90 2005 4510 4515 (Pubitemid 41159334)